Influence of pathogenic somatic mutations on the survival rates of patients with neuroendocrine tumors of the gastrointestinal tract (NET GI)
#3649
Introduction: Genomic sequencing of 40 tumors samples from patients diagnosed with NET GI was performed. Further, according to the results obtained, the survival rates of patients were evaluated.
Aim(s): To assess the impact of pathogenic somatic mutations on the survival rates of patients with NET GI.
Materials and methods: In 9 samples out of 40, pathogenic mutations were detected. In the studied samples there were such mutations as PTEN (2.5%) (+BRCA1), PIK3CA (2.5%), RB1 (2.5%) (+BRCA2), CHEK2 (2.5%) (+POLE), MLH1 (2.5%) (+BRCA1), t790m (2.5%) (+BRCA1). The most frequent mutations were BRCA1 (7.5%) and BRCA2 (7.5%).
Conference:
Presenting Author: Androsova A
Authors: Androsova A, Orlova R, Gordiev M, Ivanova A, Belyak N,
Keywords: NET, mutations, BRCA, POLE, Genomic sequencing,
To read the full abstract, please log into your ENETS Member account.